Small-Volume Continuous Manufacturing of Merestinib. Part 2. Technology Transfer and cGMP Manufacturing

Author:

Reizman Brandon J.1ORCID,Cole Kevin P.1ORCID,Hess Molly1,Burt Justin L.1,Maloney Todd D.1,Johnson Martin D.1,Laurila Michael E.1,Cope Richard F.1,Luciani Carla V.1ORCID,Buser Jonas Y.1,Campbell Bradley M.1,Forst Mindy B.1,Mitchell David1ORCID,Braden Timothy M.1,Lippelt Christopher K.1,Boukerche Moussa1,Starkey Derek R.1,Miller Richard D.1,Chen Jing2,Sun Baoquan2,Kwok Martin2,Zhang Xin2,Tadayon Sam2,Huang Ping2

Affiliation:

1. Small Molecule Design and Development, Eli Lilly and Company, Indianapolis, Indiana 46285, United States

2. Shanghai SynTheAll Pharmaceutical Co., Ltd. (“STA”), No. 13 Building, #90 Delin Rd, WaiGaoQiao Free Trade Zone, Shanghai 200131, People’s Republic of China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Physical and Theoretical Chemistry

Reference26 articles.

1. Kilogram-scale prexasertib monolactate monohydrate synthesis under continuous-flow CGMP conditions

2. Palmer, E. Lilly commits to continuous manufacturing with Ireland plant. Fierce Pharma, Questex, LLC, April 5, 2016. https://www.fiercepharma.com/manufacturing/lilly-commits-to-continuous-manufacturing-ireland-plant.

3. How GSK Launched a Continuous Manufacturing Pilot Plant — And What It Learned. Pharmaceutical Online, Vertmarkets, Inc., July 10, 2017. https://www.pharmaceuticalonline.com/doc/how-gsk-launched-a-continuous-manufacturing-pilot-plant-and-what-it-learned-0001.

4. Garguilo, L. Novartis and the Arrival of the Continuous Manufacturing Facility. Outsourced Pharma, Vertmarkets, Inc., February 8, 2017. https://www.outsourcedpharma.com/doc/novartis-and-the-arrival-of-the-continuous-manufacturing-facility-0001.

5. Pfizer opens modern continuous manufacturing plant. io-consultants, io-consultants GmbH & Co. KG, May 30, 2017. https://en.io-consultants.com/meta/news_events/Pfizer_opens_modern_continuous_manufacturing_plant/415-detail.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3